OmniAb (OABI) FCF Margin (2022 - 2026)

OmniAb (OABI) reported FCF Margin of 35.22% for Q1 2026, up 35190.0% year-over-year from N/an in Q1 2025, and up 48.09% quarter-over-quarter from 67.85% in Q4 2025.

OmniAb (OABI) FCF Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of FCF Margin data on file, last reported at 35.22% in Q1 2026.

  • FCF Margin for Q1 2026 came in at 35.22%, up 35190.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 89.91% (up 5339.0% YoY), and the FY2025 annual result was 198.33%, down 4774.0% from the prior year.
  • FCF Margin grew to 35.22% in Q1 2026 per OABI's latest filing, from 67.85% in the prior quarter.
  • Over five years, FCF Margin peaked at 162.27% in Q1 2023 and troughed at 460.3% in Q1 2024.
  • A 5-year average of 131.73% and a median of 94.56% in 2023 frame the typical range for FCF Margin.
  • The sharpest annual moves came in 2024 and 2026: FCF Margin sank 62257 bps in 2024, then surged 35190 bps in 2026.
  • A 5-year view of FCF Margin shows it stood at 10.2% in 2022, then tumbled by 1885 bps to 202.41% in 2023, then soared by 90 bps to 19.62% in 2024, then slumped by 246 bps to 67.85% in 2025, then soared by 48 bps to 35.22% in 2026.
  • Business Quant data shows OABI's FCF Margin at 35.22% in Q1 2026, 67.85% in Q4 2025, and 444.17% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn -35.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 -35.22%
Dec 31, 2025 -67.85%
Sep 30, 2025 -444.17%
Jun 30, 2025 -136.28%
Mar 31, 2025 -387.12%
Dec 31, 2024 -19.62%
Sep 30, 2024 -197.79%
Jun 30, 2024 -155.94%
Mar 31, 2024 -460.30%
Dec 31, 2023 -202.41%
Sep 30, 2023 -94.56%
Jun 30, 2023 -155.99%
Mar 31, 2023 162.27%
Dec 31, 2022 -10.20%
Sep 30, 2022 -60.67%
Jun 30, 2022 -68.65%
Mar 31, 2022 95.09%